|
| Status |
Public on Jul 01, 2009 |
| Title |
M022 |
| Sample type |
RNA |
| |
|
| Source name |
Whole blood from patient with septicemic melioidosis
|
| Organism |
Homo sapiens |
| Characteristics |
Age: 18
Gender: M
Ethnicity: Not Hispanic or Latino
Race: Asian
Illness: Sepsis/Melioidosis
Treatment: Ceftazidime, Cactrim
Pathogen: B.pseudomallei
|
| Extracted molecule |
total RNA |
| Extraction protocol |
Tempus Spin Isolation Kit
|
| Label |
biotin
|
| Label protocol |
Biotinylated cRNA were generated following manufacturer protocols using the Illumina TotalPrep Amplification Kit from Ambion
|
| |
|
| Hybridization protocol |
Hybridize 6-Sample Beadchip
|
| Scan protocol |
SentrixScanVersion 2.3.0.13 (This information is in the .XML file)
|
| Description |
The subject was infected with B.pseudomallei
|
| Data processing |
The data were analysed using BeadStudio version 1.5.1.3 using the average chip normalization method.
|
| |
|
| Submission date |
Oct 02, 2008 |
| Last update date |
May 29, 2009 |
| Contact name |
Damien Chaussabel |
| E-mail(s) |
[email protected]
|
| Organization name |
Baylor Institute for Immunology Research
|
| Street address |
3434 Live Oak
|
| City |
Dallas |
| State/province |
TX |
| ZIP/Postal code |
75204 |
| Country |
USA |
| |
|
| Platform ID |
GPL6106 |
| Series (1) |
| GSE13015 |
Genomic Transcriptional Profiling Identifies a Blood Biomarker Signature for the Diagnosis of Septicemic Melioidosis |
|
